Literature DB >> 12364355

Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II.

Ulf Landmesser1, Hua Cai, Sergey Dikalov, Louise McCann, Jinah Hwang, Hanjoong Jo, Steven M Holland, David G Harrison.   

Abstract

Hypertension caused by angiotensin II is dependent on vascular superoxide (O2*-) production. The nicotinamide adenine dinucleotide phosphate (NAD[P]H) oxidase is a major source of vascular O2*- and is activated by angiotensin II in vitro. However, its role in angiotensin II-induced hypertension in vivo is less clear. In the present studies, we used mice deficient in p47(phox), a cytosolic subunit of the NADPH oxidase, to study the role of this enzyme system in vivo. In vivo, angiotensin II infusion (0.7 mg/kg per day for 7 days) increased systolic blood pressure from 105+/-2 to 151+/-6 mm Hg and increased vascular O2*- formation 2- to 3-fold in wild-type (WT) mice. In contrast, in p47(phox-/-) mice the hypertensive response to angiotensin II infusion (122+/-4 mm Hg; P<0.05) was markedly blunted, and there was no increase of vascular O2*- production. In situ staining for O2*- using dihydroethidium revealed a marked increase of O2*-production in both endothelial and vascular smooth muscle cells of angiotensin II-treated WT mice, but not in those of p47(phox-/-) mice. To directly examine the role of the NAD(P)H oxidase in endothelial production of O2*-, endothelial cells from WT and p47(phox-/-) mice were cultured. Western blotting confirmed the absence of p47(phox) in p47(phox-/-) mice. Angiotensin II increased O2*- production in endothelial cells from WT mice, but not in those from p47(phox-/-) mice, as determined by electron spin resonance spectroscopy. These results suggest a pivotal role of the NAD(P)H oxidase and its subunit p47(phox) in the vascular oxidant stress and the blood pressure response to angiotensin II in vivo.

Entities:  

Keywords:  Non-programmatic

Mesh:

Substances:

Year:  2002        PMID: 12364355      PMCID: PMC4734745          DOI: 10.1161/01.hyp.0000032100.23772.98

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  27 in total

1.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

2.  Endothelial regulation of vasomotion in apoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin.

Authors:  J B Laursen; M Somers; S Kurz; L McCann; A Warnholtz; B A Freeman; M Tarpey; T Fukai; D G Harrison
Journal:  Circulation       Date:  2001-03-06       Impact factor: 29.690

3.  Angiotensin II-induced superoxide anion generation in human vascular endothelial cells: role of membrane-bound NADH-/NADPH-oxidases.

Authors:  H Zhang; A Schmeisser; C D Garlichs; K Plötze; U Damme; A Mügge; W G Daniel
Journal:  Cardiovasc Res       Date:  1999-10       Impact factor: 10.787

4.  Systemic and Regional Hemodynamic Responses to Tempol in Angiotensin II-Infused Hypertensive Rats.

Authors:  Akira Nishiyama; Toshiki Fukui; Yoshihide Fujisawa; Matlubur Rahman; Run-Xia Tian; Shoji Kimura; Youichi Abe
Journal:  Hypertension       Date:  2001-01       Impact factor: 10.190

5.  Role of NAD(P)H oxidase in angiotensin II-induced JAK/STAT signaling and cytokine induction.

Authors:  B Schieffer; M Luchtefeld; S Braun; A Hilfiker; D Hilfiker-Kleiner; H Drexler
Journal:  Circ Res       Date:  2000-12-08       Impact factor: 17.367

6.  Validation of lucigenin (bis-N-methylacridinium) as a chemilumigenic probe for detecting superoxide anion radical production by enzymatic and cellular systems.

Authors:  Y Li; H Zhu; P Kuppusamy; V Roubaud; J L Zweier; M A Trush
Journal:  J Biol Chem       Date:  1998-01-23       Impact factor: 5.157

7.  p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats.

Authors:  T Fukui; N Ishizaka; S Rajagopalan; J B Laursen; Q Capers; W R Taylor; D G Harrison; H de Leon; J N Wilcox; K K Griendling
Journal:  Circ Res       Date:  1997-01       Impact factor: 17.367

8.  Vascular superoxide production and vasomotor function in hypertension induced by deoxycorticosterone acetate-salt.

Authors:  M J Somers; K Mavromatis; Z S Galis; D G Harrison
Journal:  Circulation       Date:  2000-04-11       Impact factor: 29.690

9.  Validation of lucigenin as a chemiluminescent probe to monitor vascular superoxide as well as basal vascular nitric oxide production.

Authors:  M P Skatchkov; D Sperling; U Hink; A Mülsch; D G Harrison; I Sindermann; T Meinertz; T Münzel
Journal:  Biochem Biophys Res Commun       Date:  1999-01-19       Impact factor: 3.575

10.  The p47phox mouse knock-out model of chronic granulomatous disease.

Authors:  S H Jackson; J I Gallin; S M Holland
Journal:  J Exp Med       Date:  1995-09-01       Impact factor: 14.307

View more
  184 in total

Review 1.  Endothelium-derived vasoactive factors and hypertension: possible roles in pathogenesis and as treatment targets.

Authors:  Michel Félétou; Ralf Köhler; Paul M Vanhoutte
Journal:  Curr Hypertens Rep       Date:  2010-08       Impact factor: 5.369

Review 2.  A rational basis for selection among drugs of the same class.

Authors:  Morris J Brown
Journal:  Heart       Date:  2003-06       Impact factor: 5.994

Review 3.  Novel NAD(P)H oxidases in the cardiovascular system.

Authors:  K K Griendling
Journal:  Heart       Date:  2004-05       Impact factor: 5.994

Review 4.  Vascular oxidative stress: the common link in hypertensive and diabetic vascular disease.

Authors:  Richard A Cohen; XiaoYong Tong
Journal:  J Cardiovasc Pharmacol       Date:  2010-04       Impact factor: 3.105

5.  Counterpoint: Activation of the intrarenal renin-angiotensin system is the dominant contributor to systemic hypertension.

Authors:  L Gabriel Navar
Journal:  J Appl Physiol (1985)       Date:  2010-12

Review 6.  Nox isoforms in vascular pathophysiology: insights from transgenic and knockout mouse models.

Authors:  Jennifer Rivera; Christopher G Sobey; Anna K Walduck; Grant R Drummond
Journal:  Redox Rep       Date:  2010       Impact factor: 4.412

Review 7.  Angiotensin and insulin resistance: conspiracy theory.

Authors:  Raymond R Townsend
Journal:  Curr Hypertens Rep       Date:  2003-04       Impact factor: 5.369

8.  NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis.

Authors:  Ramon Bataller; Robert F Schwabe; Youkyung H Choi; Liu Yang; Yong Han Paik; Jeffrey Lindquist; Ting Qian; Robert Schoonhoven; Curt H Hagedorn; John J Lemasters; David A Brenner
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

Review 9.  Role of NADPH oxidases in liver fibrosis.

Authors:  Yong-Han Paik; Jonghwa Kim; Tomonori Aoyama; Samuele De Minicis; Ramon Bataller; David A Brenner
Journal:  Antioxid Redox Signal       Date:  2014-01-24       Impact factor: 8.401

10.  Angiotensin II induces a region-specific hyperplasia of the ascending aorta through regulation of inhibitor of differentiation 3.

Authors:  A Phillip Owens; Venkateswaran Subramanian; Jessica J Moorleghen; Zhenheng Guo; Coleen A McNamara; Lisa A Cassis; Alan Daugherty
Journal:  Circ Res       Date:  2009-12-17       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.